chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.66
Sex: M
Vaccine: HEP, HEP, IPV
Symptoms: Abnormal behaviour, Antisocial behaviour, Autism, Cellulitis, Cognitive disorder
Clinical narrative: Initial report received from another manufacturer on 9/27/06 report number WAES0412USA03224. Information had been received by this reporter secondary to a case in litigation. Follow up information was received by the manufacture in the form of medical records. Name and address of the reporter was noted as confidential. A two year old male pt had received a third dose, SC injection of IPOL, lot number K1014 and a third dose , IM injection of Hep B vaccine lot number 613671/1288A, on 1/29/96. He had also received a fourth dose, left thigh injection of Tetramune, lot number 434812, a first doe SC injection of MMR II lot number 612888/373A, and a first dose right arm, SC injection of varicella vaccine, lot number 616338/0559D on 9/9/1996. It was reported that, at an unspecified time, the pt had experienced toxic mercury exposure secondary to mercury emissions from power plants, the mercury in thimerosal laden products and via food chain. Per the report, minor male suffered serious and permanent neurological damage with associated learning disabilities, disorders and impairments. From information based upon medical records, sixteen months following the IPOL vaccination, on 6/23/97 at two years of age, the pt was noted to have a language delay and was scheduled for a developmental assessment. On 9/29/97, the pt was seen for a psychological evaluation and was diagnosed with autism and had greater the 25% delay for his age in all areas of developmental and adaptive functioning. It was noted that he was at high risk for mental retardation. Recommended treatment included special instruction, speech and language therapy, behavior management services and placement in a special education preschool program specifically designed for children with autism. On 7/17/98, results of lab test noted that the pts chromosomes were normal 46xy and fragile X was neg. Autism was considered by the reporter to be an important medical event (OMIC). At the time of this report the pt had not recovered.
Age: 0.66
Sex: M
Vaccine: HEP, HEP, IPV
Symptoms: Cough, Cyst, Eczema, Enuresis, Injury
Clinical narrative: Initial report received from another manufacturer on 9/27/06 report number WAES0412USA03224. Information had been received by this reporter secondary to a case in litigation. Follow up information was received by the manufacture in the form of medical records. Name and address of the reporter was noted as confidential. A two year old male pt had received a third dose, SC injection of IPOL, lot number K1014 and a third dose , IM injection of Hep B vaccine lot number 613671/1288A, on 1/29/96. He had also received a fourth dose, left thigh injection of Tetramune, lot number 434812, a first doe SC injection of MMR II lot number 612888/373A, and a first dose right arm, SC injection of varicella vaccine, lot number 616338/0559D on 9/9/1996. It was reported that, at an unspecified time, the pt had experienced toxic mercury exposure secondary to mercury emissions from power plants, the mercury in thimerosal laden products and via food chain. Per the report, minor male suffered serious and permanent neurological damage with associated learning disabilities, disorders and impairments. From information based upon medical records, sixteen months following the IPOL vaccination, on 6/23/97 at two years of age, the pt was noted to have a language delay and was scheduled for a developmental assessment. On 9/29/97, the pt was seen for a psychological evaluation and was diagnosed with autism and had greater the 25% delay for his age in all areas of developmental and adaptive functioning. It was noted that he was at high risk for mental retardation. Recommended treatment included special instruction, speech and language therapy, behavior management services and placement in a special education preschool program specifically designed for children with autism. On 7/17/98, results of lab test noted that the pts chromosomes were normal 46xy and fragile X was neg. Autism was considered by the reporter to be an important medical event (OMIC). At the time of this report the pt had not recovered.
Age: 0.66
Sex: M
Vaccine: HEP, HEP, IPV
Symptoms: Mental impairment, Obesity, Otitis media, Rash, Rhinorrhoea
Clinical narrative: Initial report received from another manufacturer on 9/27/06 report number WAES0412USA03224. Information had been received by this reporter secondary to a case in litigation. Follow up information was received by the manufacture in the form of medical records. Name and address of the reporter was noted as confidential. A two year old male pt had received a third dose, SC injection of IPOL, lot number K1014 and a third dose , IM injection of Hep B vaccine lot number 613671/1288A, on 1/29/96. He had also received a fourth dose, left thigh injection of Tetramune, lot number 434812, a first doe SC injection of MMR II lot number 612888/373A, and a first dose right arm, SC injection of varicella vaccine, lot number 616338/0559D on 9/9/1996. It was reported that, at an unspecified time, the pt had experienced toxic mercury exposure secondary to mercury emissions from power plants, the mercury in thimerosal laden products and via food chain. Per the report, minor male suffered serious and permanent neurological damage with associated learning disabilities, disorders and impairments. From information based upon medical records, sixteen months following the IPOL vaccination, on 6/23/97 at two years of age, the pt was noted to have a language delay and was scheduled for a developmental assessment. On 9/29/97, the pt was seen for a psychological evaluation and was diagnosed with autism and had greater the 25% delay for his age in all areas of developmental and adaptive functioning. It was noted that he was at high risk for mental retardation. Recommended treatment included special instruction, speech and language therapy, behavior management services and placement in a special education preschool program specifically designed for children with autism. On 7/17/98, results of lab test noted that the pts chromosomes were normal 46xy and fragile X was neg. Autism was considered by the reporter to be an important medical event (OMIC). At the time of this report the pt had not recovered.
Age: 0.66
Sex: M
Vaccine: HEP, HEP, IPV
Symptoms: Speech disorder, Upper respiratory tract infection
Clinical narrative: Initial report received from another manufacturer on 9/27/06 report number WAES0412USA03224. Information had been received by this reporter secondary to a case in litigation. Follow up information was received by the manufacture in the form of medical records. Name and address of the reporter was noted as confidential. A two year old male pt had received a third dose, SC injection of IPOL, lot number K1014 and a third dose , IM injection of Hep B vaccine lot number 613671/1288A, on 1/29/96. He had also received a fourth dose, left thigh injection of Tetramune, lot number 434812, a first doe SC injection of MMR II lot number 612888/373A, and a first dose right arm, SC injection of varicella vaccine, lot number 616338/0559D on 9/9/1996. It was reported that, at an unspecified time, the pt had experienced toxic mercury exposure secondary to mercury emissions from power plants, the mercury in thimerosal laden products and via food chain. Per the report, minor male suffered serious and permanent neurological damage with associated learning disabilities, disorders and impairments. From information based upon medical records, sixteen months following the IPOL vaccination, on 6/23/97 at two years of age, the pt was noted to have a language delay and was scheduled for a developmental assessment. On 9/29/97, the pt was seen for a psychological evaluation and was diagnosed with autism and had greater the 25% delay for his age in all areas of developmental and adaptive functioning. It was noted that he was at high risk for mental retardation. Recommended treatment included special instruction, speech and language therapy, behavior management services and placement in a special education preschool program specifically designed for children with autism. On 7/17/98, results of lab test noted that the pts chromosomes were normal 46xy and fragile X was neg. Autism was considered by the reporter to be an important medical event (OMIC). At the time of this report the pt had not recovered.
Age: 0.66
Sex: M
Vaccine: HEP, HEP, IPV
Symptoms: Autism, Drug toxicity, Mental retardation severity unspecified, Nervous system disorder, Personality disorder
Clinical narrative: Initial report received from another manufacturer on 9/27/06 report number WAES0412USA03224. Information had been received by this reporter secondary to a case in litigation. Follow up information was received by the manufacture in the form of medical records. Name and address of the reporter was noted as confidential. A two year old male pt had received a third dose, SC injection of IPOL, lot number K1014 and a third dose , IM injection of Hep B vaccine lot number 613671/1288A, on 1/29/96. He had also received a fourth dose, left thigh injection of Tetramune, lot number 434812, a first doe SC injection of MMR II lot number 612888/373A, and a first dose right arm, SC injection of varicella vaccine, lot number 616338/0559D on 9/9/1996. It was reported that, at an unspecified time, the pt had experienced toxic mercury exposure secondary to mercury emissions from power plants, the mercury in thimerosal laden products and via food chain. Per the report, minor male suffered serious and permanent neurological damage with associated learning disabilities, disorders and impairments. From information based upon medical records, sixteen months following the IPOL vaccination, on 6/23/97 at two years of age, the pt was noted to have a language delay and was scheduled for a developmental assessment. On 9/29/97, the pt was seen for a psychological evaluation and was diagnosed with autism and had greater the 25% delay for his age in all areas of developmental and adaptive functioning. It was noted that he was at high risk for mental retardation. Recommended treatment included special instruction, speech and language therapy, behavior management services and placement in a special education preschool program specifically designed for children with autism. On 7/17/98, results of lab test noted that the pts chromosomes were normal 46xy and fragile X was neg. Autism was considered by the reporter to be an important medical event (OMIC). At the time of this report the pt had not recovered.
Age: 0.66
Sex: M
Vaccine: HEP, HEP, IPV
Symptoms: Speech disorder
Clinical narrative: Initial report received from another manufacturer on 9/27/06 report number WAES0412USA03224. Information had been received by this reporter secondary to a case in litigation. Follow up information was received by the manufacture in the form of medical records. Name and address of the reporter was noted as confidential. A two year old male pt had received a third dose, SC injection of IPOL, lot number K1014 and a third dose , IM injection of Hep B vaccine lot number 613671/1288A, on 1/29/96. He had also received a fourth dose, left thigh injection of Tetramune, lot number 434812, a first doe SC injection of MMR II lot number 612888/373A, and a first dose right arm, SC injection of varicella vaccine, lot number 616338/0559D on 9/9/1996. It was reported that, at an unspecified time, the pt had experienced toxic mercury exposure secondary to mercury emissions from power plants, the mercury in thimerosal laden products and via food chain. Per the report, minor male suffered serious and permanent neurological damage with associated learning disabilities, disorders and impairments. From information based upon medical records, sixteen months following the IPOL vaccination, on 6/23/97 at two years of age, the pt was noted to have a language delay and was scheduled for a developmental assessment. On 9/29/97, the pt was seen for a psychological evaluation and was diagnosed with autism and had greater the 25% delay for his age in all areas of developmental and adaptive functioning. It was noted that he was at high risk for mental retardation. Recommended treatment included special instruction, speech and language therapy, behavior management services and placement in a special education preschool program specifically designed for children with autism. On 7/17/98, results of lab test noted that the pts chromosomes were normal 46xy and fragile X was neg. Autism was considered by the reporter to be an important medical event (OMIC). At the time of this report the pt had not recovered.
Age: 28.0
Sex: F
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: CSF test abnormal, Chills, Headache, Herpes simplex serology negative, Nuclear magnetic resonance imaging
Clinical narrative: 28 year old woman received a Varicella Zoster virus vaccine on 9/5/06. This was part of a physical exam for nursing school. Just over a week after receiving the vaccine, she noticed a small pustular rash on her skin. She represented to her physician's office and was told that this could be Varicella skin rash. Shortly afterwards, she had generalized weakness and tiredness and a runny nose. The skin rash has largely spontaneously improved over time, but she had a low grade headache which persisted through the week. 48 hours prior to admission headache became significantly worse. She is not able to eat. There is associated nausea. She dose have a history of migraine headaches, but this is completely different from her usual headaches. She was evaluated in the ER where a lumbar puncture was done. The lumbar puncture was significant for a WBC of 241 with 45% segments. Because of the severity of her headaches and the positive lumbar puncture, she was referred in for hospitalization. She does not have a change in her visual acuity. There is no sore throat or gum bleeding. There is no neck pain or neck swelling.
Age: 28.0
Sex: F
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Pain, Polymerase chain reaction, Protein total, Pyrexia, Rash
Clinical narrative: 28 year old woman received a Varicella Zoster virus vaccine on 9/5/06. This was part of a physical exam for nursing school. Just over a week after receiving the vaccine, she noticed a small pustular rash on her skin. She represented to her physician's office and was told that this could be Varicella skin rash. Shortly afterwards, she had generalized weakness and tiredness and a runny nose. The skin rash has largely spontaneously improved over time, but she had a low grade headache which persisted through the week. 48 hours prior to admission headache became significantly worse. She is not able to eat. There is associated nausea. She dose have a history of migraine headaches, but this is completely different from her usual headaches. She was evaluated in the ER where a lumbar puncture was done. The lumbar puncture was significant for a WBC of 241 with 45% segments. Because of the severity of her headaches and the positive lumbar puncture, she was referred in for hospitalization. She does not have a change in her visual acuity. There is no sore throat or gum bleeding. There is no neck pain or neck swelling.
Age: 28.0
Sex: F
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Rash pruritic, Skin ulcer, Varicella, White blood cell count
Clinical narrative: 28 year old woman received a Varicella Zoster virus vaccine on 9/5/06. This was part of a physical exam for nursing school. Just over a week after receiving the vaccine, she noticed a small pustular rash on her skin. She represented to her physician's office and was told that this could be Varicella skin rash. Shortly afterwards, she had generalized weakness and tiredness and a runny nose. The skin rash has largely spontaneously improved over time, but she had a low grade headache which persisted through the week. 48 hours prior to admission headache became significantly worse. She is not able to eat. There is associated nausea. She dose have a history of migraine headaches, but this is completely different from her usual headaches. She was evaluated in the ER where a lumbar puncture was done. The lumbar puncture was significant for a WBC of 241 with 45% segments. Because of the severity of her headaches and the positive lumbar puncture, she was referred in for hospitalization. She does not have a change in her visual acuity. There is no sore throat or gum bleeding. There is no neck pain or neck swelling.
Age: 28.0
Sex: F
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Fatigue, Headache, Laboratory test abnormal, Meningitis, Nausea
Clinical narrative: 28 year old woman received a Varicella Zoster virus vaccine on 9/5/06. This was part of a physical exam for nursing school. Just over a week after receiving the vaccine, she noticed a small pustular rash on her skin. She represented to her physician's office and was told that this could be Varicella skin rash. Shortly afterwards, she had generalized weakness and tiredness and a runny nose. The skin rash has largely spontaneously improved over time, but she had a low grade headache which persisted through the week. 48 hours prior to admission headache became significantly worse. She is not able to eat. There is associated nausea. She dose have a history of migraine headaches, but this is completely different from her usual headaches. She was evaluated in the ER where a lumbar puncture was done. The lumbar puncture was significant for a WBC of 241 with 45% segments. Because of the severity of her headaches and the positive lumbar puncture, she was referred in for hospitalization. She does not have a change in her visual acuity. There is no sore throat or gum bleeding. There is no neck pain or neck swelling.
Age: 28.0
Sex: F
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Rash vesicular, Rhinorrhoea
Clinical narrative: 28 year old woman received a Varicella Zoster virus vaccine on 9/5/06. This was part of a physical exam for nursing school. Just over a week after receiving the vaccine, she noticed a small pustular rash on her skin. She represented to her physician's office and was told that this could be Varicella skin rash. Shortly afterwards, she had generalized weakness and tiredness and a runny nose. The skin rash has largely spontaneously improved over time, but she had a low grade headache which persisted through the week. 48 hours prior to admission headache became significantly worse. She is not able to eat. There is associated nausea. She dose have a history of migraine headaches, but this is completely different from her usual headaches. She was evaluated in the ER where a lumbar puncture was done. The lumbar puncture was significant for a WBC of 241 with 45% segments. Because of the severity of her headaches and the positive lumbar puncture, she was referred in for hospitalization. She does not have a change in her visual acuity. There is no sore throat or gum bleeding. There is no neck pain or neck swelling.
Age: 28.0
Sex: F
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Anorexia, Asthenia, CSF test abnormal, Fatigue, Headache
Clinical narrative: 28 year old woman received a Varicella Zoster virus vaccine on 9/5/06. This was part of a physical exam for nursing school. Just over a week after receiving the vaccine, she noticed a small pustular rash on her skin. She represented to her physician's office and was told that this could be Varicella skin rash. Shortly afterwards, she had generalized weakness and tiredness and a runny nose. The skin rash has largely spontaneously improved over time, but she had a low grade headache which persisted through the week. 48 hours prior to admission headache became significantly worse. She is not able to eat. There is associated nausea. She dose have a history of migraine headaches, but this is completely different from her usual headaches. She was evaluated in the ER where a lumbar puncture was done. The lumbar puncture was significant for a WBC of 241 with 45% segments. Because of the severity of her headaches and the positive lumbar puncture, she was referred in for hospitalization. She does not have a change in her visual acuity. There is no sore throat or gum bleeding. There is no neck pain or neck swelling.
Age: 28.0
Sex: F
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Nausea, Rash pustular, Rhinorrhoea, Viral infection
Clinical narrative: 28 year old woman received a Varicella Zoster virus vaccine on 9/5/06. This was part of a physical exam for nursing school. Just over a week after receiving the vaccine, she noticed a small pustular rash on her skin. She represented to her physician's office and was told that this could be Varicella skin rash. Shortly afterwards, she had generalized weakness and tiredness and a runny nose. The skin rash has largely spontaneously improved over time, but she had a low grade headache which persisted through the week. 48 hours prior to admission headache became significantly worse. She is not able to eat. There is associated nausea. She dose have a history of migraine headaches, but this is completely different from her usual headaches. She was evaluated in the ER where a lumbar puncture was done. The lumbar puncture was significant for a WBC of 241 with 45% segments. Because of the severity of her headaches and the positive lumbar puncture, she was referred in for hospitalization. She does not have a change in her visual acuity. There is no sore throat or gum bleeding. There is no neck pain or neck swelling.
Age: 24.0
Sex: M
Vaccine: SMALL, ANTH, FLUN3, HEPAB, SMALL
Symptoms: Blister, Injection site vesicles
Clinical narrative: 09/22/06 flu like symptoms after smallpox injection 9/19/06, headache, body aches, blood streaked emesis diarrhea, rash developed on back ant right shoulder and pruritis. Chest + papular rash, pustules. D/C to quarters x 24 hours, Motrin, Tylenol T 98.7.
Age: 24.0
Sex: M
Vaccine: SMALL, ANTH, FLUN3, HEPAB, SMALL
Symptoms: Diarrhoea, Haematemesis, Headache, Influenza like illness, Pain
Clinical narrative: 09/22/06 flu like symptoms after smallpox injection 9/19/06, headache, body aches, blood streaked emesis diarrhea, rash developed on back ant right shoulder and pruritis. Chest + papular rash, pustules. D/C to quarters x 24 hours, Motrin, Tylenol T 98.7.
Age: 24.0
Sex: M
Vaccine: SMALL, ANTH, FLUN3, HEPAB, SMALL
Symptoms: Pruritus, Rash papular, Rash pustular
Clinical narrative: 09/22/06 flu like symptoms after smallpox injection 9/19/06, headache, body aches, blood streaked emesis diarrhea, rash developed on back ant right shoulder and pruritis. Chest + papular rash, pustules. D/C to quarters x 24 hours, Motrin, Tylenol T 98.7.
Age: 30.0
Sex: M
Vaccine: YF
Symptoms: Eye disorder, Face oedema, Lacrimation increased, Pruritus, Rhinorrhoea
Clinical narrative: Runny nose, itchy water eyes, swollen upper lip. Symptom onset 5 minutes after receiving YF vaccine. Tx with 50 ng/dl Benadryl IM. Immediately relieved symptoms.
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: Anaphylactic reaction
Clinical narrative: Information has been received from a health professional concerning a 4 year old male who was vaccinated with a 0.5ml dose of MMR II/Varicella. Suspect vaccination that day included other shots (unspecified). Subsequently the pt experienced an anaphylactic response and was hospitalized (duration unk). There was no product quality complaint involved. Additional information has been requested.
Age: 1.07
Sex: F
Vaccine: DTAP, HEPA, HIBV, MMRV, PNC
Symptoms: Agitation, Convulsion, Crying, Febrile convulsion, Haematochezia
Clinical narrative: Inconsolable crying, slight rash on back and trunk. Seen by private physician, treated for ear infection 9/13/06. On 9/15/06 temp of 102 with Tylenol for 4-5 hrs on afternoon. Seizure activity for 2 hrs, life flighted to Hospital. admitted 9/15/06 discharged 9/17/06. DOS 09/15-09/17/06 DC DX: status epilepticus, probably complexed febrile seizure. Seizure activity felt to be a febrile event.  HX of present illness: treated for otitis media continued to run low grade fevers getting higher on day of admission followed subsequently by three to four short bursts of seizures this evening prior to admission, over a two hour period. Temp 37.0
Age: 1.07
Sex: F
Vaccine: DTAP, HEPA, HIBV, MMRV, PNC
Symptoms: Lung infiltration, Otitis media, Pyrexia, Rash, Status epilepticus
Clinical narrative: Inconsolable crying, slight rash on back and trunk. Seen by private physician, treated for ear infection 9/13/06. On 9/15/06 temp of 102 with Tylenol for 4-5 hrs on afternoon. Seizure activity for 2 hrs, life flighted to Hospital. admitted 9/15/06 discharged 9/17/06. DOS 09/15-09/17/06 DC DX: status epilepticus, probably complexed febrile seizure. Seizure activity felt to be a febrile event.  HX of present illness: treated for otitis media continued to run low grade fevers getting higher on day of admission followed subsequently by three to four short bursts of seizures this evening prior to admission, over a two hour period. Temp 37.0
Age: 0.15
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Abnormal behaviour, Agitation, Electroencephalogram abnormal, Eye movement disorder
Clinical narrative: The day after baby received Dtap, Hib, IPV, PCV while diaper changed placed hands back behind head, pushed head down, eyes rolled back, no fever, cried afterwards. Sent to ER for Sepsis workup and neurologic evaluation.  2/2/07 Received medical records from hospital which reveal patient experienced stiffening episode w/ rhythmic eye movement lasting approx 1 min, no fever.  Temp in ER was 99.7. Admitted to peds neuro  10/3-10/4/06. Neuro exam noted mild head lag & truncal hypotonia.  No further seizures.  D/C to outpatient f/u w/neuro & CT scan of head. FINAL DX: possible seizure disorder, doubt post immunization episode.
Age: 0.51
Sex: F
Vaccine: DTAP, HEP, HIBV, PNC
Symptoms: Anaphylactic reaction, Pallor, Throat tightness, Urticaria
Clinical narrative: Within 60 seconds of receiving 6 month immunizations IE Dtap 3, Hep B 3, Hib 3, Prevnar 3 Pt developed pallor, airway compromise and numerous hives over abdomen, arms, legs. 10/26/06-records reviewed for DOS 10/02/06-Assessment by PCP in hospital: anaphylaxis. Evaluation by allergy requested. Keep overnight for observation.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Dehydration, Febrile convulsion, Otitis media
Clinical narrative: 09/20/2006 fever, seizure, seen in ER discharged home. Had second seizure on 09/21/2006 and was admitted to hospital for further treatment.  10/24/06 Received medical records from hospital which revealed patient admitted on 9/21/06 with dx: seizures & fever.  AM of admit patient initial in usual state of health (with known medical anomalies ie agenesis of corpus callosum) & later that day developed head rolled back, eyes deviated & left arm & leg jerking for approx 3-4 min.  Mom & EMTs noted fluid from ears & circumoral cyanosis along with fever 103.  Returned to baseline in ER & was d/c to home w/Dx: febrile seizure.  Sleepy at home rest of day & then during the night had another seizure lasing approx 2 min.  Returned to ER where had another seizure while awaiting CT scan. Placed initially on IV antibiotics & antivirals as well as antiseizure meds.  Antibiotics & antivirals were d/c when all cultures were neg but continued on seizure meds at d/c. Birth hx: 35 wk gestation & was in NICU for about 1 month. PMH: micro deletion chromosomal anomaly with some congenital abnormalities & vertebral anomalies; VSD; GERD; developmental delay (receiveing PT/OT); & hx of recurrent OM (subsequently had PE tubes placed in 10/06). Exam noted a very tired appearing infant w/perforated right TM, obscured left TM, + systolic murmur, hypertonic extremities, long standing papular rash on cheeks & arms. LABS: all essentially WNL DX: multiple seizures in 24 hr period w/o return to baseline & associated fever; Right OM w/perforation; & mild dehydration.
Age: 45.0
Sex: M
Vaccine: ANTH, HEP, HEPA
Symptoms: Anxiety, Depression
Clinical narrative: I felt depressed and anxious.
Age: 1.0
Sex: F
Vaccine: MMRV
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician concerning a 12 month old female who on 6/5/06 was vaccinated SC with a single dose MMR II/Varicella vaccine. The physician reported that on 6/7/06, 48 hours after being vaccinated, the pt developed a fever of 102.5. Unspecified medical attention was sought and the pt was treated with Tylenol. On 6/8/06, the pt is fever resolved. The physician felt that the pts fever was caused a virus note MMM II/Varicella. The physician considered fever to be an other important medical event (OMIC). No further information is available.
Age: 52.0
Sex: M
Vaccine: ANTH
Symptoms: Anxiety, Bone pain, Chest pain, Depression, Fatigue
Clinical narrative: Body aches including bones and muscles. Body aches including bones and muscles. Fever (high temperature), blurred vision, headache. Extreme exhaustion. Nausea, Chest pain, high blood pressure. 12/19/06-records received and reviewed. krk DX:Depression Axix I: Anxiety disorder NOS MDD-moderate II None III Discogenic disease of lumbar spine and cervical spine. Chronice back pain, cervical spine and lumbar spine. Right knee pain r/o meniscus tear. IV primary group, marital separation. Military experience-military trauma and legal issues related. V GAF=50 Surgery: Laminectomy 4/2006 Rt knee meniscus 1998 and 2004.
Age: 52.0
Sex: M
Vaccine: ANTH
Symptoms: Headache, Hypertension, Injury, Myalgia, Nausea
Clinical narrative: Body aches including bones and muscles. Body aches including bones and muscles. Fever (high temperature), blurred vision, headache. Extreme exhaustion. Nausea, Chest pain, high blood pressure. 12/19/06-records received and reviewed. krk DX:Depression Axix I: Anxiety disorder NOS MDD-moderate II None III Discogenic disease of lumbar spine and cervical spine. Chronice back pain, cervical spine and lumbar spine. Right knee pain r/o meniscus tear. IV primary group, marital separation. Military experience-military trauma and legal issues related. V GAF=50 Surgery: Laminectomy 4/2006 Rt knee meniscus 1998 and 2004.
Age: 52.0
Sex: M
Vaccine: ANTH
Symptoms: Pain, Pyrexia, Vision blurred
Clinical narrative: Body aches including bones and muscles. Body aches including bones and muscles. Fever (high temperature), blurred vision, headache. Extreme exhaustion. Nausea, Chest pain, high blood pressure. 12/19/06-records received and reviewed. krk DX:Depression Axix I: Anxiety disorder NOS MDD-moderate II None III Discogenic disease of lumbar spine and cervical spine. Chronice back pain, cervical spine and lumbar spine. Right knee pain r/o meniscus tear. IV primary group, marital separation. Military experience-military trauma and legal issues related. V GAF=50 Surgery: Laminectomy 4/2006 Rt knee meniscus 1998 and 2004.
Age: 68.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site pain, Pyrexia, Tenderness, White blood cell count increased
Clinical narrative: Left upper arm pain and tenderness, fever, elevated WBC count.
Sex: M
Vaccine: FLUX, PPV
Symptoms: Injection site rash, Injection site warmth, Renal pain, Urinary retention
Clinical narrative: 10/5, rash on arm, 10/6, pain in left kidney area, rash extended from injection site to elbow, very hot. Trouble urinating. Seen by doctor the the afternoon and started on treatment with Keflex (4 X/day). Tylenol for pain and warm/moist compresses. Rash almost gone today. Pain in kidney area continues. Relief of medication only lasts 4-6 hours.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Chest pain, Cough, Dyspnoea, Fatigue
Clinical narrative: High fever, ache (body) difficult breathing, tightness in chest, headache, coughing, sharp chest pain, fatigue, burned vision.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Headache, Pain, Pyrexia, Vision blurred
Clinical narrative: High fever, ache (body) difficult breathing, tightness in chest, headache, coughing, sharp chest pain, fatigue, burned vision.
Age: 28.0
Sex: M
Vaccine: ANTH
Symptoms: Headache, Neck pain, Pyrexia, Somnolence, Stomach discomfort
Clinical narrative: Pt seen in ER on 04/15/2006 at 16:15 with c/o fever of 101.7F within 24 hours; headache, upset stomach, neck pain with extension and increased sleeping. Pt had pain scale of 9/10 X 2-3 days. Pt was treated with normal saline IV, Tylenol, Motrin, Rocephin and Phenergan. CT done on 4/15/06 was normal. Pt was discharged at 21:15. Neurological exam was normal.
Age: 21.0
Sex: M
Vaccine: FLUN3, SMALL
Symptoms: Erythema, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: 21 year old male presented to ER with local reaction to smallpox vaccine, had smallpox shot a wk ago. When going to bed noted area raised and painful with red strip on upper arm with red streak to axilla. Given Toradol 60 mg IM in ER. Wound dressed, sent home, F/U in am.
Age: 6.0
Sex: M
Vaccine: MMRV
Symptoms: Pyrexia, Rash morbilliform, Rash pruritic, Vomiting
Clinical narrative: Vomiting and slight fever on 10/2/06 day of vaccine, itchy rash mobilliform on day 3 generalized.
Age: 6.0
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Oedema, Tenderness
Clinical narrative: Right arm swollen, slightly erythematous and tender.
Age: 52.0
Sex: M
Vaccine: ANTH, HEP, MEN
Symptoms: Arthralgia, Back pain, Diarrhoea, Insomnia, Muscular weakness
Clinical narrative: Joints pain, diarrhea, muscular weakness, insomnia, Skin rash back pain.
Age: 52.0
Sex: M
Vaccine: ANTH, HEP, MEN
Symptoms: Rash
Clinical narrative: Joints pain, diarrhea, muscular weakness, insomnia, Skin rash back pain.
Age: 1.25
Sex: M
Vaccine: DTAP, MMRV
Symptoms: Rash, Urticaria
Clinical narrative: Mild hives, rash on truck of body, oral Benadryl, OTC 4-6 Hours.
Age: 74.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Headache
Clinical narrative: Pt complained of headache 5 min after injections. Placed pt on left side SXS within normal limit. Headache after 15 min. Pt remained on left side for additional 15 min. SXS continued within normal limit called pt at 4:00 pm husband stated she is out driving and feels fine.
Age: 40.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site oedema, Injection site pain, Injection site reaction, Joint range of motion decreased
Clinical narrative: 4 hours after injection given pt developed fever 101 right arm, red sore arm, swelling in shoulder arm. She went to the ER SC with type 4 reaction to protein in the vaccine. Pt and nausea, declined pain and and nausea meds. As of 10/06/06 pt still has pain and is not able to have full ROM of arm and shoulder. Is followed by PCP. RXN in right arm Pneumovax in right deltoid.
Age: 40.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Nausea, Pyrexia
Clinical narrative: 4 hours after injection given pt developed fever 101 right arm, red sore arm, swelling in shoulder arm. She went to the ER SC with type 4 reaction to protein in the vaccine. Pt and nausea, declined pain and and nausea meds. As of 10/06/06 pt still has pain and is not able to have full ROM of arm and shoulder. Is followed by PCP. RXN in right arm Pneumovax in right deltoid.
Age: 1.08
Sex: F
Vaccine: MMRV
Symptoms: Medication error
Clinical narrative: PT given ProQuad 9/27/06 expiration date on injection 8/8/06, no problems noted.
Age: 44.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Unevaluable event
Clinical narrative: None Stated
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Dysphonia, Pruritus, Throat tightness
Clinical narrative: Hoarse voice, voice strangled, coughing frequently, throat not clearing, itching palms, head, arms and legs, inside body, tight air way, no wheezing. BP 115/67, HR 74. Refused to go to ED took 50 mg PO Benadryl. S/S subsided within 1 hour.
Sex: U
Vaccine: HEPA, MMRV
Symptoms: Injection site erythema, Injection site induration, Injection site rash, Injection site reaction, Rash macular
Clinical narrative: Child has 2 inch long hard indurated blanching red macular rash on left ant thigh site of ProQuad vaccine 2 days ago. No fever, doesn't feel ill at all.
Age: 17.0
Sex: M
Vaccine: HEP, MNQ, TDAP
Symptoms: Hypotension, Malaise, Pallor, Syncope
Clinical narrative: Pt experienced a near syncopal episode at 9:30am. client A&O x 3. Client upon standing turned pale and stated he felt funny. Client placed supine and lifted feet. V/S bp 86/50 at 9:30am, bp 100/64 at 9:35am pulse 66 reg.
Age: 46.0
Sex: M
Vaccine: ANTH
Symptoms: Agitation, Anxiety, Arthralgia, Balance disorder, Blister
Clinical narrative: Ache in joints and muscles; agitation; mood: anxiety; balance; vertigo; dizzy; blood pressure varies; blisters in right hand and right foot; high cholesterol; coordination problems; concentration trouble; anxious; depression; skin pain; papules filled with clear fluid and when papules broke, fluid burned skin and was extremely painful; tachycardia; thinking abnormally; tiredness; vision problems, possible glaucoma; walking difficulty; insomnia (unable to sleep flat without medication); stomach problems; night sweats.
Age: 46.0
Sex: M
Vaccine: ANTH
Symptoms: Coordination abnormal, Depression, Disturbance in attention, Fatigue, Hypercholesterolaemia
Clinical narrative: Ache in joints and muscles; agitation; mood: anxiety; balance; vertigo; dizzy; blood pressure varies; blisters in right hand and right foot; high cholesterol; coordination problems; concentration trouble; anxious; depression; skin pain; papules filled with clear fluid and when papules broke, fluid burned skin and was extremely painful; tachycardia; thinking abnormally; tiredness; vision problems, possible glaucoma; walking difficulty; insomnia (unable to sleep flat without medication); stomach problems; night sweats.
Age: 46.0
Sex: M
Vaccine: ANTH
Symptoms: Hypertension, Hypotension, Insomnia, Myalgia, Night sweats
Clinical narrative: Ache in joints and muscles; agitation; mood: anxiety; balance; vertigo; dizzy; blood pressure varies; blisters in right hand and right foot; high cholesterol; coordination problems; concentration trouble; anxious; depression; skin pain; papules filled with clear fluid and when papules broke, fluid burned skin and was extremely painful; tachycardia; thinking abnormally; tiredness; vision problems, possible glaucoma; walking difficulty; insomnia (unable to sleep flat without medication); stomach problems; night sweats.
Age: 46.0
Sex: M
Vaccine: ANTH
Symptoms: Rash papular, Stomach discomfort, Tachycardia, Thinking abnormal, Vertigo
Clinical narrative: Ache in joints and muscles; agitation; mood: anxiety; balance; vertigo; dizzy; blood pressure varies; blisters in right hand and right foot; high cholesterol; coordination problems; concentration trouble; anxious; depression; skin pain; papules filled with clear fluid and when papules broke, fluid burned skin and was extremely painful; tachycardia; thinking abnormally; tiredness; vision problems, possible glaucoma; walking difficulty; insomnia (unable to sleep flat without medication); stomach problems; night sweats.
Age: 46.0
Sex: M
Vaccine: ANTH
Symptoms: Visual disturbance
Clinical narrative: Ache in joints and muscles; agitation; mood: anxiety; balance; vertigo; dizzy; blood pressure varies; blisters in right hand and right foot; high cholesterol; coordination problems; concentration trouble; anxious; depression; skin pain; papules filled with clear fluid and when papules broke, fluid burned skin and was extremely painful; tachycardia; thinking abnormally; tiredness; vision problems, possible glaucoma; walking difficulty; insomnia (unable to sleep flat without medication); stomach problems; night sweats.
Age: 1.05
Sex: M
Vaccine: MMRV
Symptoms: Rash
Clinical narrative: Information has been received from a health professional concerning a 11 month old white male with bilateral otitis media who on 27-Mar-2006 was vaccinated in the left thigh with a first dose of measles virus vaccine live  (+) mumps virus vaccine live (+0 rubella virus vaccine live (+) varicella virus vaccine live (lot#651815/0950R).  On 24-Apr-2006 the patient developed a rash on his stomach, back and chest.  Medical attention was not sought.  On an unspecified date the patient recovered from the rash.  There was no product quality complaint involved.  Additional information is not expected.
Age: 1.0
Sex: U
Vaccine: MMRV
Symptoms: Dyskinesia, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 12 month old patient who on 31-May-2006 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live.  Soon after the patient presented with a "head jerking to the left side", occurring frequently on the first day.  Several days later it reduced to sporadic or a couple of times during the day.  The patient had a lump on the left lateral thigh of 1.5 cm where the patient had the injection.  The infant was seen on 06-Jun-2006 and still had a grade fever.
Age: 1.0
Sex: M
Vaccine: MMRV
Symptoms: Pyrexia
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 12-month-old male with no pertinent medical history, who on 03-Jun-2006 was vaccinated subsequently with a 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot#652332/1122R).  There was no concomitant medication. "last week",on approximately 05-Jun-2006 the patient developed a high fever of 104 degrees Fahrenheit and went to the emergency room.  He was treated and released.  It was noted that he had a temperature of 99.8 degrees Fahrenheit for 24 hours.  The patient recovered.  No product quality complaint was involved.  Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Erythema, Unevaluable event
Clinical narrative: Information has been received from a health care professional concerning a patient who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus  vaccine live (+) varicella virus vaccine live.  On 12-Jun-2006 it was reported that in the "past few weeks" the patient was vaccinated.  The day after the patient developed a reaction and broke out in generalized redness that spontaneously resolved.  Unspecified medical attention was sought.  There was no product quality complaint involved.  Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMRV
Symptoms: Injection site erythema, Injection site induration, Injection site reaction, Rash
Clinical narrative: Information has been received from a health professional concerning a 12 month old female who on 12-Jun-2006 was vaccinated with a first 0.5 ml subcutaneous of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus  vaccine live (lot#652680/1133R). On 12-Jun-2006 the patient developed and immediate injection site reaction, with a 2 cm rash with induration and extended redness about 1/2 inch below the injection site.  There were no other symptoms noted.  The reaction was described as "looking like a bug bite".  Unspecified medical attention was sought.  No product quality was involved.  No other information was provided.   Additional information has been requested.
Age: 1.25
Sex: M
Vaccine: MMRV
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician concerning a 15 month old male who on approximately 07-Jun-2006 was vaccinated SC with a 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine (+) varicella virus vaccine live.  Subsequently the patient experienced a fever and a bump.  Unspecified medical attention was sought.  As of 14-Jun-2006 the patient was recovering.  There was no quality involved.  Additional information has been requested.
Age: 1.08
Sex: M
Vaccine: MMRV
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Information has been received from a physician concerning a 13 month old male with no known medical history or allergies who on 06-May-2006 was vaccinated with a SC 0.5 ml first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) rubella virus vaccine live.  There was no concomitant medication.  "Two days after receiving" the vaccine, on 16 May 2006 the patient developed a measles live rash.  The patient also had an ear infection.  Unspecified medical attention was sought.  He was treated with azithromycin (ZITHROMAX).  No laboratory diagnostic tests were performed.  Subsequently, the patient recovered.  There was no product quality complaint involved.  Additional information has been requested.
Age: 1.11
Sex: F
Vaccine: MMRV
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a consumer concerning her niece a 13 month old female who "about a week ago" on approximately 09-Jun-2006 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live.  On 12 Jun 2006 the patient developed a fever and rash of red bumps on her face and chest.  No other symptoms were even noted.  Medical attention was not sought.  There was no product quality complaint involved.
Age: 1.0
Sex: F
Vaccine: MMRV
Symptoms: Injection site erythema, Injection site induration, Injection site reaction, Rash
Clinical narrative: Information has been received from a health professional concerning a 12 month old female who on 12 Jun 2006 was vaccinated with a first 0.5 ml subcutaneous dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+0 varicella virus vaccine live (lot#65268c/113R).  On 12 Jun 2006 the patient developed and immediate injection site reaction, with a  2 cm rash with induration and extended redness about 1/2 inch below the injection site.  There were no other symptoms noted.  The reaction was described as "looking like a bug bite".  Unspecified attention was sought.  No product quality complaint was involved.  No other information was provided.  Additional information has been requested.
Age: 1.34
Sex: M
Vaccine: MMRV
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Information has been received from a physician concerning a 16 month old male with no history or allergies, who on 05-Jun-2006 was vaccinated with a 0.5 ml dos eof measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live (lot#"1032R").  There was no concomitant medication.  The patient presented to the physician's office on 20-Jun-2006 with a mild case of chicken pox which started "a couple of days ago".  There were no labs performed.  The patient's chicken pox persisted.  There was no product quality complaint received.
Age: 1.0
Sex: M
Vaccine: MMRV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a health professional concerning a 1 year old male who on 15-Jun-2006 was vaccinated with SC with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live.  The patient had concomitant medications however the reporter didn't "know which ones".  On 22-Jun-2006 the healthcare worker reported that she "just found out today" the patient experienced redness and swelling at the injection site.  Unspecified medical attention was sought.  At the time of the report the patient was recovering.  There was no product complaint involved.  Additional information has been requested.
Age: 38.0
Sex: F
Vaccine: MMRV
Symptoms: Nausea
Clinical narrative: Information has been received through the manufacturer mentioned pregnancy registry from a physician concerning a 38 year old female with no known medical history or allergies who on 02-Jun-2006 was vaccinated with a 0.5 ml SC dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live (lot#652325/0953R).  There was no concomitant medication.  After the vaccination the patient called the office complaining of nausea and was given a pregnancy test on 19-Jun-2006.  The pregnancy test was positive.  At the time of the report the patient was "three weeks pregnant", with her LMP of approximately 01-Jun-2006.  There was no product quality complaint involved. Additional information has been requested. Follow-up information was received from a nurse who reported that the "office" was unable to contact the patient, and therefore she had no information regarding the pregnancy outcome of the patient.